These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2844005)

  • 21. [Treatment of deep venous thrombosis with fractions of low molecular weight heparin].
    Faivre R; Ducellier D; Kieffer Y; Bassand JP; Maurat JP
    Therapie; 1988 May; 43(3):183-5. PubMed ID: 2844003
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double-blind randomized comparative study of enoxaparin and standard heparin in the prevention of thromboembolic disease during insertion of total hip replacement].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman G; Landais A; Weill D; Pascariello JC; Butel J
    Rev Med Interne; 1988; 9(3):327-33. PubMed ID: 2841742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 24. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF; Aebi B
    Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised evaluation of treatment modalities in thromboembolic disorders.
    ten Cate JW; Büller HR
    Haematologica; 1999 Jun; 84 Suppl EHA-4():85-7. PubMed ID: 10907478
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
    Agnelli G; Cimminiello C
    Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
    Andersen JC
    Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine.
    Alfaro MJ; Páramo JA; Rocha E
    Thromb Haemost; 1986 Aug; 56(1):53-6. PubMed ID: 3535158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparins in orthopaedic surgery.
    Drug Ther Bull; 1993 May; 31(10):37-8. PubMed ID: 8393759
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thromboembolic disease and changes in coagulation after total hip arthroplasty. Effect of prophylaxis with acetylsalicylic acid or heparin-dihydroergotamine].
    Alfaro M; Páramo JA; de Pablos J; Cañadell J; Rocha E
    Sangre (Barc); 1986; 31(2):145-55. PubMed ID: 3726711
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing the risk of venous thromboembolism in orthopedics: concluding remarks.
    Haas S
    Orthopedics; 1997 Feb; 20 Suppl():26-7. PubMed ID: 9048405
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of thromboembolic disease in urologic surgery with low-dose heparin].
    Lancina Martín JA; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986; 39(9):591-7. PubMed ID: 3827326
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
    Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter 2: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Tangelder MJ; Bylock A; Held P
    Br J Surg; 2006 Mar; 93(3):374-5; author reply 375-6. PubMed ID: 16498578
    [No Abstract]   [Full Text] [Related]  

  • 38. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D; Hirsh J; Heit J; Prins M; Davidson B; Lensing AW
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparin, low-molecular-weight heparin and their clinical use].
    Neri Serneri GG
    Ann Ital Med Int; 1993; 8(2):69-72. PubMed ID: 8394728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of thromboembolism with low molecular weight heparin in orthopedics and traumatology].
    Barsotti J; Rosset P; Planes A; Marchal C; Robert C; Bertrand P
    Ann Fr Anesth Reanim; 1992; 11(3):318-24. PubMed ID: 1323941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.